About this Research Topic
There are emerging evidence of non-pharmacologic therapeutics for psychiatric illnesses to modulate brain activity, often referred to as “neuromodulation”, which is a broad term that could technically be considered to cover any medical, surgical, or physiologic therapy designed to alter the function of the nervous system in some manner. In the clinical neurosciences, however, neuromodulation is understood to refer specifically to therapies that involve targeted delivery of electrical current or magneic field, which includes electroconvulsive therapy (ECT), one of the oldest treatments in psychiatry, and Vagus Nerve Stimulation (VNS), approved by the FDA in 2005 for severe depression, and repetitive Transcranial Magnetic Stimulation (rTMS), approved by the FDA in 2008 for the treatment of major depression. Recently, the studies using transcranial direct current stimulation (tDCS), vagal nerve stimulation (VNS), trigeminal nerve stimulation (TNS) and deep brain stimulation (DBS) have been also reported in a growing trend. To develop more effective treatments for psychiatric diseases, translational approaches bridging basic and clinical evidence deserves considerations.
In this Research Topic, we will provide a forum for researchers interested in basic, translational and clinical research of neuromodulation for psychiatric illnesses and aim to facilitate an integrative view of neuromodulation, to foster discussion across disciplines, and to stimulate collaboration.
Keywords: tDCS, rTMS, mECT, DBS, Neurofeedback
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.